Spectrum News| May 2021

Spectrum Equity’s Jeff Haywood and Steve LeSieur Named to GrowthCap’s 2021 Top 25 Healthcare Investors List

Spectrum Equity is proud to announce Jeff Haywood and Steve LeSieur have been recognized by GrowthCap for their contributions as top growth equity investors in healthcare. Together they lead Spectrum’s investment activity in healthcare, focusing on high growth Internet-enabled software and information services companies serving consumers and enterprises in all parts of the healthcare market. They serve key roles in establishing and fostering long-standing partnerships with CEOs and management teams and help them accelerate growth through product innovation as well as economic and market opportunity expansion. They have also helped guide management teams through several successful exits to strategic acquirers, financial sponsors and the public markets. Learn more about our healthcare investments here.

Jeff Haywood & Steve LeSieur, Managing Directors
Jeff Haywood and Steve LeSieur lead Spectrum Equity’s investment activity in healthcare, focusing on high growth Internet-enabled software and information services companies serving all parts of the healthcare market.

Steve joined Spectrum in 2005 and currently serves on the following healthcare company boards including GoodRx (NASDAQ: GDRX) and Payer Compass and was previously involved with Definitive Healthcare, MedHOK (acquired by Hearst Health), HealthMEDX (acquired by NetSmart), Passport Health Communications (acquired by Experian) and QTC Management (acquired by Lockheed Martin).

Jeff joined the firm in 2007 and currently serves on the following healthcare company boards including Definitive Healthcare, Payer Compass, RxVantage and Verisys. He also led Spectrum’s recent investment in PWNHealth and subsequent sale to Everlywell, where he continues as a board observer. Jeff was previously involved with GoodRx (NASDAQ: GDRX), MedHOK (acquired by Hearst Health), Net Health (acquired by The Carlyle Group), and Passport Health Communications (acquired by Experian).

"Spectrum Equity is committed to fostering long-standing partnerships with the founders and entrepreneurs building today’s market leading digital health companies. It is incredibly rewarding to support the efforts of management teams addressing the highly complex issues that exist, and are often unique, in healthcare. We believe the ongoing evolution of connected software, data and analytics will continue to have a massive impact on healthcare both in terms of increasing access to care and improving outcomes.” – Steve LeSieur & Jeff Haywood

Content contained in this blog post is not intended to and does not constitute investment advice. Your use of the information in this blog post and materials linked is at your own risk. Spectrum Equity does not make any guarantee or other promise as to any results that may be obtained from using this content. No one should make any investment decision without first consulting his or her own financial advisor and conducting his or her own research and due diligence. Past performance is not indicative of future results, and there is a possibility of loss in connection with an investment in any Spectrum Fund. To the maximum extent permitted by law, Spectrum Equity disclaims any and all liability in the event any information, commentary, analysis, and/or opinions prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses. The specific companies identified above does not represent all of Spectrum’s investments, and no assumptions should be made that any investments identified were or will be profitable.